Assert-IQ vs Rapid Enterprise Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott Medical

Rapid Enterprise Platform

by RapidAI

AI Verdict

Assert-IQ is an insertable cardiac monitor that uses AI for long-term, continuous heart rhythm monitoring and arrhythmia detection. Rapid Enterprise Platform, on the other hand, is a broader AI platform that connects imaging to clinical action across various specialties, including cardiology, neurology, and radiology. While both utilize AI in cardiology, Assert-IQ is a specialized device for cardiac rhythm monitoring, whereas Rapid Enterprise Platform is an overarching AI solution for image-based diagnostics and workflow integration.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous cardiac monitoring for comprehensive arrhythmia detection in patients with suspected heart rhythm disorders or those at risk for cardiac arrhythmias. This tool is ideal for diagnosing unexplained symptoms like dizziness, palpitations, chest pain, or syncope, and for monitoring patients with diagnosed atrial fibrillation. Its minimally invasive insertion and remote monitoring capabilities make it suitable for extended patient management.

View Assert-IQ →

Choose Rapid Enterprise Platform if…

Choose Rapid Enterprise Platform if your organization requires a comprehensive, FDA-cleared AI solution that integrates imaging to clinical action across various specialties within a health system. This platform is best suited for hospitals and large health systems looking to enhance decision-making, improve workflow efficiency, and leverage deep clinical AI for advanced insights in areas like cardiology, neurology, and radiology. Its enterprise-grade security, compliance, and integration capabilities with EHRs and PACS make it ideal for complex, multi-departmental deployments.

View Rapid Enterprise Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Rapid Enterprise Platform
Pricing	Enterprise	Unknown
Deployment	Hybrid	Hybrid (cloud-first with on-premise capabilities), On-Premise, Cloud
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated
EHR Integration	Not specified	Allscripts, athenahealth, cerner, Epic, harris-healthcare, MEDITECH

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid Enterprise Platform

Rapid Enterprise Platform offers a mobile app for real-time collaboration and alerts, and integrates with existing EHRs and PACS systems, suggesting a more streamlined and integrated user experience for clinicians. Assert-IQ, while offering remote monitoring and patient symptom logging via a patient activator, does not explicitly mention a clinician-facing mobile app or direct EHR/PACS integration in its core features, though it does connect to a clinic's portal.

Clinical Value

Rapid Enterprise Platform

Rapid Enterprise Platform provides 'deep clinical AI' across multiple disease states (neurology, cardiology, radiology) with over 750 clinical studies validating its solutions, indicating a broader and more extensively validated clinical impact. Assert-IQ focuses specifically on long-term cardiac monitoring and arrhythmia detection, with its AI algorithms demonstrating high sensitivity and reduction of false positives in AF detection, but its scope is narrower.

Pricing & Value

Tie

Both tools list 'enterprise' pricing and require direct contact for details, making it impossible to compare specific costs. Neither provides transparent pricing information publicly. Therefore, based on the available information, a definitive winner cannot be determined for this dimension.

Enterprise Readiness

Rapid Enterprise Platform

Rapid Enterprise Platform is designed for hospitals and health systems, boasts over 2,500 customers in 100+ countries, and offers extensive integrations with EHRs, PACS, and other systems, along with enterprise-grade security and compliance (HIPAA, BAA, SOC2, GDPR). Assert-IQ targets large health systems, hospitals, and cardiology clinics, and is HIPAA compliant, but its enterprise features and integrations appear less extensive in comparison.

Innovation

Rapid Enterprise Platform

Rapid Enterprise Platform emphasizes 'deep clinical AI' across various imaging modalities and disease states, with a hybrid cloud-first infrastructure and continuous optimization through data and analytics, showcasing a broader innovative approach to AI in healthcare. Assert-IQ's innovation lies in its long-term continuous cardiac monitoring (up to 6 years) and advanced AI algorithms for arrhythmia detection, which are significant within its specific domain, but less expansive than RapidAI's platform.

Support & Docs

Rapid Enterprise Platform

RapidAI offers 24/7 customer support, professional education through 'Rapid U,' and extensive resources like webinars, white papers, and a publication library. Assert-IQ provides remote monitoring capabilities and proactive clinician alerts, but detailed information on comprehensive customer support, training programs, or extensive documentation beyond product manuals is not as explicitly highlighted.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Rapid Enterprise Platform
Name	Assert-IQ	Rapid Enterprise Platform
Company	Abbott Medical	RapidAI
Description	The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	RapidAI's Enterprise Platform offers FDA-cleared, deep clinical AI solutions that connect imaging to clinical action across the health system, integrating with EHRs and PACS for enhanced decision-making and workflow efficiency.
Mobile App	none	yes
API Available	no	yes
Key Features	Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion	Deep clinical AI for advanced insights, Workflow integration with EHR, PACS, and other systems, Enterprise-grade security and compliance, Data and analytics for performance optimization, FDA-cleared AI across multiple body regions, Radiology's AI interface for case prioritization (Navigator Pro), Full suite of neurocritical assessment tools, Complete ischemic stroke solution

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Rapid Enterprise Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and clinical workflows?

Assert-IQ integrates with a clinic's portal, transmitting real-time cardiac data via Bluetooth from the ICM, and offers remote programmability to reduce clinic workflow burden. RapidAI's Enterprise Platform offers deep integration with EHRs, PACS, and other systems using pre-built connectors and healthcare-specific data models, including FHIR and HL7 adapters, to streamline workflows and enhance decision-making.

What are the key differences in accuracy and sensitivity for arrhythmia detection?

Assert-IQ utilizes advanced AI algorithms that reduce false positives for AF and Pause episodes by 81% and 91% respectively, while maintaining high sensitivity (100% patient sensitivity for AF detection in studies). RapidAI's platform offers FDA-cleared AI solutions across multiple body regions, connecting imaging to clinical action, but specific accuracy and sensitivity metrics for cardiac arrhythmia detection are not detailed in the provided information.

Given their specialized focus, which tool is a better fit for a multi-specialty hospital versus a dedicated cardiology clinic?

Assert-IQ is specifically designed for long-term cardiac monitoring and arrhythmia detection, making it highly suitable for cardiology clinics and practices focused on heart rhythm disorders. RapidAI's Enterprise Platform, with its deep clinical AI solutions across cardiology, neurology, radiology, critical care, emergency medicine, and vascular surgery, is better suited for multi-specialty hospitals requiring comprehensive imaging-to-clinical-action capabilities across various departments.

What is the typical learning curve for physicians and clinical staff to effectively use each system?

Assert-IQ aims to reduce data burden and transform device detections into a more curated, decision-ready view through its AI classification, which should simplify the review process for clinicians. RapidAI emphasizes a 'rapid build sprint' for deployment, aiming for a production-ready instance in as little as 45 days, and offers guided implementation and training, suggesting a focus on efficient onboarding and user adoption.

What kind of audit trail and data governance features do these platforms offer?

Assert-IQ's AI algorithms work in the cloud to classify episodes before data reaches the clinic review queue, providing a more curated view for decision-making, and the system transmits real-time clinical data to a portal. RapidAI's platform includes role-based governance with audit logs and data quality guardrails and lineage tracking, ensuring a comprehensive audit trail and robust data governance for integrated systems.